CytomX Therapeutics, Inc. Quarterly Current Ratio in % from Q2 2016 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
CytomX Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q2 2016 to Q3 2024.
  • CytomX Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 110 %, a 22.5% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 110 -31.9 -22.5% Sep 30, 2024
Q2 2024 118 -29.5 -20.1% Jun 30, 2024
Q1 2024 126 -43.4 -25.7% Mar 31, 2024
Q4 2023 132 -73.1 -35.7% Dec 31, 2023
Q3 2023 142 -122 -46.3% Sep 30, 2023
Q2 2023 147 -174 -54.2% Jun 30, 2023
Q1 2023 169 -203 -54.6% Mar 31, 2023
Q4 2022 205 -247 -54.7% Dec 31, 2022
Q3 2022 264 -210 -44.3% Sep 30, 2022
Q2 2022 321 -131 -28.9% Jun 30, 2022
Q1 2022 372 -56.5 -13.2% Mar 31, 2022
Q4 2021 452 +70 +18.3% Dec 31, 2021
Q3 2021 474 +114 +31.8% Sep 30, 2021
Q2 2021 452 +68.8 +17.9% Jun 30, 2021
Q1 2021 429 +23 +5.68% Mar 31, 2021
Q4 2020 382 -37.2 -8.88% Dec 31, 2020
Q3 2020 359 -85.4 -19.2% Sep 30, 2020
Q2 2020 383 -87.3 -18.6% Jun 30, 2020
Q1 2020 406 -59.1 -12.7% Mar 31, 2020
Q4 2019 419 -71.1 -14.5% Dec 31, 2019
Q3 2019 445 -86.2 -16.2% Sep 30, 2019
Q2 2019 471 -54.7 -10.4% Jun 30, 2019
Q1 2019 465 -95.8 -17.1% Mar 31, 2019
Q4 2018 490 -63 -11.4% Dec 31, 2018
Q3 2018 531 +7.43 +1.42% Sep 30, 2018
Q2 2018 525 -33.9 -6.06% Jun 30, 2018
Q1 2018 561 -60.7 -9.77% Mar 31, 2018
Q4 2017 553 -213 -27.8% Dec 31, 2017
Q3 2017 524 -439 -45.6% Sep 30, 2017
Q2 2017 559 -440 -44.1% Jun 30, 2017
Q1 2017 621 Mar 31, 2017
Q4 2016 766 Dec 31, 2016
Q3 2016 963 Sep 30, 2016
Q2 2016 999 Jun 30, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.